Multidrug resistance of cancer cells and the vital role of P-glycoprotein

C Karthika, R Sureshkumar, M Zehravi, R Akter, F Ali… - Life, 2022 - mdpi.com
P-glycoprotein (P-gp) is a major factor in the multidrug resistance phenotype in cancer cells.
P-gp is a protein that regulates the ATP-dependent efflux of a wide range of anticancer …

Multi-Drug Resistance and Breast Cancer Progression via Toll-Like Receptors (TLRs) Signaling

H Pallathadka, AQ Khaleel, AH Zwamel… - Cell Biochemistry and …, 2024 - Springer
Toll-like receptors (TLRs) are essential receptors involved in inflammation and innate
immunity. Various types of cancer cells, as well as innate immune cells, express TLRs …

Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action

M Behroozaghdam, M Dehghani, A Zabolian… - Cellular and Molecular …, 2022 - Springer
Breast cancer (BC) is one of the most common cancers in females and is responsible for the
highest cancer-related deaths following lung cancer. The complex tumor microenvironment …

[HTML][HTML] Effective targeting of breast cancer by the inhibition of P-glycoprotein mediated removal of toxic lipid peroxidation byproducts from drug tolerant persister cells

K Szebényi, A Füredi, E Bajtai, SN Sama… - Drug Resistance …, 2023 - Elsevier
Therapy resistance has long been considered to occur through the selection of pre-existing
clones equipped to survive and quickly regrow, or through the acquisition of mutations …